Translating GPCR science into new medicines
Beacon Discovery is a privately held company founded in 2016. Our mission is to efficiently identify and advance molecules targeting G-Protein Coupled Receptors from concept to clinic.
September 6, 2016:
Beacon Discovery Inc. Launches as New GPCR-focused Drug Discovery Incubator
San Diego, CA